Berberine inhibits lipopolysaccharide- and polyethylene particle-induced mouse calvarial osteolysis in vivo

Journal of Surgical Research

Volumn 173, Issue 2, 2012, Pages

  Zhou, Xiaoxiao ^a,c   Zhang, Chao ^b   Wang, Xiaoqing ^c   An, Bingchen ^c   Zhang, Peng ^d   Zhu, Zhen'an ^c  

^a TAIZHOU CENTRAL HOSPITAL   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

berberine; calvarium; lipopolysaccharide; osteolysis; polyethylene particles

Indexed keywords

BERBERINE; LIPOPOLYSACCHARIDE; POLYETHYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DISEASE; CALVARIAL OSTEOLYSIS; CONTROLLED STUDY; DRUG EFFECT; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; SURFACE PROPERTY;

ANIMALS; BERBERINE; JOINT PROSTHESIS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; OSTEOLYSIS; PHYTOTHERAPY; POLYETHYLENE; SKULL;

EID: 84862787650     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.11.004     Document Type: Article

References (40)

1. Taki N, Tatro JM, Lowe R, et al. Comparison of the roles of IL-1, IL-6, and TNFα in cell culture and murine models of aseptic loosening. Bone 2007;40:1276.
2. Ragab AA, Van De Motter R, Lavish SA, et al. Measurement and removal of adherent endotoxin from titanium particles and implant surfaces. J Orthop Res 1999;17:803.
3. Skoglund B, Larsson L, Aspenberg PA. Bone-resorptive effects of endotoxin-contaminated high-density polyethylene particles spontaneously eliminated in vivo. J Bone Joint Surg Br 2002; 84:767.
4. Tatro JM, Taki N, Islam AS, et al. The balance between endotoxin accumulation and clearance during particle-induced osteolysis in murine calvaria. J Orthop Res 2007;25:361.
5. Henderson B, Poole S, Wilson M. Bacterial modulins: A novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 1996;60:316.
6. Merritt K, Panigutti MA, Kraay MJ, et al. Incidence of infection and analysis of contributing factors in revision joint arthroplasty over a two-year period. J Appl Biomater 1994; 5:103.
7. Tunney MM, Patrick S, Curran MD, et al. Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J Clin Microbiol 1999;37:3281.
8. Espehaug B, Engesaeter LB, Vollset SE, et al. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br 1997; 79:590.
9. Dixon RA. Natural products and plant disease resistance. Nature 2001;411:843.
10. Asai M, Iwata N, Yoshikawa A, et al. Berberine alters the processing of Alzheimer's amyloid precursor protein to decrease A- secretion. Biochem Biophys Res Commun 2007;352:498.
11. Birdsall TC, Kelly GS. Berberine: Therapeutic potential of an alkaloid found in several medicinal plants. Altern Med Rev 1997;2:94.
12. Lee YS, Kim WS, Kim KH, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006;55:2256.
13. Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004;10:1344-51. (Pubitemid 40022716)
14. Anis KV, Rajeshkumar NV, Kuttan R. Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pharm Pharmacol 2001;53:763-8. (Pubitemid 32457828)
15. Mantena SK, Sharma SD, Katiyar SK. Berberine, a natural product, induces G1- phase cell cycle arrest and caspase-3- dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 2006;5:296.
16. Hu JP, Takahashi N, Yamada T. Coptidis rhizoma inhibits growth and proteases of oral bacteria. Oral Dis 2000;6:297.
17. Xu D, Yang W, Zhou C, et al. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats. Planta Med 2010; 76:1809.
18. Hayashi K, Minoda K, Nagaoka Y, et al. Antiviral activity of berberine and related compounds against human cytomegalovirus. Bioorg Med Chem Lett 2007;17:1562.
19. Park KD, Lee JH, Kim SH, et al. Synthesis of 13-(substituted benzyl) berberine and berberrubine derivatives as antifungal agents. Bioorg Med Chem Lett 2006;16:3913.
20. Ivanovska N, Philipov S, Hristova M. Influence of berberine on T-cell mediated immunity. Immunopharmacol Immunotoxicol 1999;21:771.
21. Ivanovska N, Philipov S. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int J Immunopharmacol 1996;18:553.
22. Marinova EK, Nikolova DB, Popova DN, et al. Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/c mice by berberine. Immunopharmacology 2000;48:9.
23. Mao Y, Zhu Z, Tang T, Dai K. Different Phagocytosis Reaction of Macrophages on UHMWPE and Ti-6AI-4V Particles. Journal of Shanghai Jiaotong University (Medical Science) 2006;26:476 [in Chinese].
24. Zhou X, Zhang P, Zhang C, Zhu Z. Promotion of bone formation by naringin in a titanium particle-induced diabetic murine calvarial osteolysis model. J Orthop Res 2010;28:451.
25. Yip KH, Zheng MH, Feng HT, et al. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-κB activity. J Bone Miner Res 2004; 19:1905.
26. Letasiová S, Jantová S, Múcková M, et al. Antiproliferative activity of berberine in vitro and in vivo. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005;149:461.
27. von Knoch M, Wedemeyer C, Pingsmann A, et al. The decrease of particle-induced osteolysis after a single dose of bisphosphonate. Biomaterials 2005;26:1803.
28. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: Standardization of nomenclature, symbols and units. Report of the ASMBR histomorphometry nomenclature committee. J Bone Miner Res 1987;2:595.
29. Goodman S, Aspenberg P, Song Y, et al. Tissue in-growth and differentiation in the bone-harvest chamber in the presence of cobaltchromium-alloy and high-density-polyethylene particles. J Bone Joint Surg Am 1995;77:1025.
30. Friedman RJ, Black J, Galante JO, et al. Current concepts in orthopaedic biomaterials and implant fixation. J Bone Joint Surg Am 1994;75:1086.
31. Skoglund B, Larsson L, Aspenberg PA. Bone-resorptive effects of endotoxin-contaminated high-density polyethylene particles spontaneously eliminated in vivo. J Bone Joint Surg Br 2002; 84:767.
32. Nair SP, Meghji S, Wilson M, et al. Bacterially induced bone destruction: Mechanisms and misconceptions. Infect Immune 1996;64:2371.
33. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998;282:2085.
34. Shuto T, Jimi E, Kukita T, et al. Granulocyte macrophage colony stimulating factor suppresses lipopolysaccharide-induced osteoclast-like cell formation in mouse bone marrow cultures. Endocrinology 1994;134:831.
35. Takami M, Kim N, Rho J, et al. Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol 2002;169:1516.
36. Wang X, Qiu S, Yao X, et al. Berberine inhibits Staphylococcus epidermidis adhesion and biofilm formation on the surface of titanium alloy. J Orthop Res 2009;27:1487.
37. Wang X, Yao X, Zhu Z, et al. Effect of berberine on Staphylococcus epidermidis biofilm formation. Int J Antimicrob Agents 2009;34:60.
38. Li H, Miyahara T, Tezuka Y, et al. The effect of kampo formulae on bone resorption in vitro and in vivo. II. Detailed study of berberine. Biol Pharm Bull 1999;22:391.
39. Hu JP, Nishishita K, Sakai E, et al. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-κB and Akt pathways. Eur J Pharmacol 2008;580:70.
40. Kaar SG, Ragab AA, Kaye SJ, et al. Rapid repair of titanium particle-induced osteolysis is dramatically reduced in aged mice. J Orthop Res 2001;19:171.